USPTO serial 79451511
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drugs for medical purposes; anti-cancer drugs; anti-cancer preparations; compounds for treating cancer; biopharmaceuticals for the treatment of cancer; pharmaceuticals; pharmaceutical drugs; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; sanitary preparations for medical purposes; dietetic preparations for medical purposes; adjuvants for medical purposes; antiseptics; medicinal products for human medical purposes; bacteriological preparations for medical purposes; bacteriological preparations for pharmaceutical use; biological preparations for medical purposes; chemicals for pharmaceutical use; chemical preparations for medical purposes; chemical preparations for veterinary purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; dietary substances for medical purposes; protein preparations for medical purposes; elixirs (pharmaceutical preparations); feed additives for medical purposes; in vitro diagnostic preparations for medical purposes; capsules for medical purposes; germicidal detergents; dietary supplements for medical purposes; pharmaceutical preparations; preparations for sterilization. | ACTIVE | — |
| 010 | Apparatus for the treatment of cancer; medical instruments; surgical, medical, dental and veterinary instruments and apparatus; surgical sutures; electromedical diagnostic instruments; analysers for medical purposes; apparatus for physical rehabilitation for medical purposes; diagnostic devices for medical purposes; medical instruments for therapeutic drug monitoring. | ACTIVE | — |
| 042 | Scientific research for medical purposes in the area of cancerous diseases; pharmaceutical products development; scientific and technological services and research in the field of chemistry, biotechnology, biopharmacy and medicine; preparation of biotechnological and biopharmaceutical analyses; development of new diagnostic methods; services in the field of developing new medicines, as included in this class; development of medical and veterinary preparations and medicines; biological research; chemical research and analysis services; chemical laboratory services; conducting chemical analyses; conducting scientific research; research in the field of bacteriology; research in the field of chemistry; research and development services relating to new products for third parties; scientific research; medical research in the field of rare diseases; research and development in the pharmaceutical and biotechnology fields. | ACTIVE | — |
| 044 | Medical and veterinary services; medical laboratory services; conducting medical and clinical examinations; medical analysis services for cancer diagnosis and prognosis; laboratory analysis services relating to the treatment of persons. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 1, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 1, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 23, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 22, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 12, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 12, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 11, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |